Medpace: Full CRO Model Builds Net Revenue Growth, Maintain At Strong Buy
Source: SeekingAlpha
2025-10-23 16:52:14 ET
The last time I spoke about Medpace Holdings, Inc. ( MEDP ), it was in a Seeking Alpha article entitled "Medpace's Global CRO Reach Lends Credibility For Its 2025 Revenue Guidance Increase." I noted that in the release of its Q2 of 2025 earnings, it beat expectations for starters. Not only that, but it even raised its full-year guidance for 2025....
Read the full article on Seeking Alpha
For further details see:
Medpace: Full CRO Model Builds Net Revenue Growth, Maintain At Strong Buy
Medpace Holdings Inc.
NASDAQ: MEDP
MEDP Trading
-0.75% G/L:
$450.99 Last:
111,208 Volume:
$450.52 Open:
MEDP Latest News
February 23, 2026 12:10:00 am
Ongoing Investigation: Medpace Holdings, Inc. (MEDP) May Have Misled Shareholders - Levi & Korsinsky Investigates
February 18, 2026 09:00:00 am
Medpace Holdings Under Investigation After Book-to-Bill Miss Exposes Cancellation Surge and Pipeline Fragility
February 16, 2026 01:50:00 pm
Why Big Stock Swings Like Medpace's 55% Jump Usually Have Clear Causes--Not Market Madness
MEDP Stock Data
$12,487,114,097
22,450,074
3.25%
359
N/A
Biotechnology & Life Sciences
Healthcare
US
Cincinnati
